Options Update: Dendreon options indicate movement into data


Dendreon (NYSE: DNDN) was halted at $7.30. DNDN is reporting top-line data from the ongoing Phase 3 IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment) this morning. DNDN April 7 straddle is priced at $1.87, May 7 straddle is priced at $6.60 according to Track Data, suggesting large price movement.

NASDAQ 100 (NASDAQ:QQQQ) overall implied volatility at 36; 26-week average is 43. CBOE Volatility Index S&P 500 Options-VIX at 37.81; 10-day moving average is 40.82.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Symbol Lookup
IndexesChangePrice
DJIA+47.0012,848.23
NASDAQ+18.822,922.70
S&P 500+5.361,348.00

Last updated: February 13, 2012: 01:06 PM

Hot Stocks

General Electric

19.045+0.17(+0.90)

Alcoa

10.355+0.065(+0.63)

Apple Inc

499.02+5.60(+1.13)

Google Inc 'A'

612.56+6.65(+1.10)

Bank of America

8.275+0.205(+2.54)

Wal-Mart Stores

61.88-0.02(-0.03)

Exxon Mobil Corp

84.34+0.54(+0.64)

Ford

12.545+0.105(+0.84)

Citigroup

33.39+0.465(+1.41)

IBM

192.80+0.38(+0.20)

Yahoo

16.15+0.01(+0.06)

Starbucks

49.16+0.34(+0.70)

Microsoft

30.58+0.085(+0.28)

Home Depot

45.815+0.485(+1.07)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329156412221 ms.